Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06825208
What this trial is testing

Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial

Who this might be right for
Small Cell Lung Cancer Extensive StageELDERLY PEOPLE
Nanjing First Hospital, Nanjing Medical University 29
Testing effectiveness (Phase 2)Study completedNCT00582725
What this trial is testing

R-CHOP + GM-CSF for Previously Untreated LCL in Elderly

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
University of Wisconsin, Madison 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT07416110
What this trial is testing

Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine

Who this might be right for
Rabies (Healthy Volunteers)
Sinovac Biotech Co., Ltd 912
Testing effectiveness (Phase 2)UnknownNCT03728374
What this trial is testing

Anlotinib Hydrochloride as Second-line Therapy in Elderly Patients With EGFR Wild-type Lung Adenocarcinoma

Who this might be right for
Non-Small-Cell Lung Cancer
First Affiliated Hospital of Wenzhou Medical University 38
Large-scale testing (Phase 3)Looking for participantsNCT07068074
What this trial is testing

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Who this might be right for
Cutaneous Melanoma
ECOG-ACRIN Cancer Research Group 428
Testing effectiveness (Phase 2)Study completedNCT01077713
What this trial is testing

Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 86
Testing effectiveness (Phase 2)UnknownNCT00907348
What this trial is testing

Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma

Who this might be right for
Non Hodgkin LymphomaFollicular Lymphoma
Fondazione Italiana Linfomi - ETS 49
Not applicableEnded earlyNCT01204216
What this trial is testing

Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c

Who this might be right for
Diabetes MellitusImpaired Fasting GlucosePrediabetes
VA Office of Research and Development 3
Large-scale testing (Phase 3)Looking for participantsNCT07215585
What this trial is testing

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

Who this might be right for
Large B-cell Lymphoma
AstraZeneca 420
Testing effectiveness (Phase 2)Study completedNCT05913024
What this trial is testing

Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months

Who this might be right for
Healthy Volunteers
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 470
Large-scale testing (Phase 3)Study completedNCT01093196
What this trial is testing

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 660
Testing effectiveness (Phase 2)UnknownNCT03949062
What this trial is testing

Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02590003
What this trial is testing

Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small Cell Lung
Yale University 3
Testing effectiveness (Phase 2)Looking for participantsNCT06828991
What this trial is testing

Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Danielle Wallace 40
Testing effectiveness (Phase 2)Study completedNCT02888990
What this trial is testing

Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Acute
Versailles Hospital 71
Large-scale testing (Phase 3)Active Not RecruitingNCT06447779
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 25,000
Early research (Phase 1)UnknownNCT04982068
What this trial is testing

Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Who this might be right for
COVID-19
Shanghai Zerun Biotechnology Co.,Ltd 72
Early research (Phase 1)Not Yet RecruitingNCT07705464
What this trial is testing

Safety Study of Intravenous MiraMSC in Older Adults With Mild to Moderate Frailty Syndrome

Who this might be right for
Frailty
Miracle Biomedical Co., Ltd. 12
Not applicableUnknownNCT03749681
What this trial is testing

Neuroendocrine Tumors of Old Patients in the West of France

Who this might be right for
Neuroendocrine Tumors
University Hospital, Brest 306
Testing effectiveness (Phase 2)Study completedNCT02372006
What this trial is testing

Trial of Afatinib in Pediatric Tumours

Who this might be right for
Neuroectodermal TumorsRhabdomyosarcoma
Boehringer Ingelheim 56
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation